PTEN loss and BRAF mutation are frequent in melanoma, and these two events may cooperate in the transformation of melanocytes: in fact, it was shown that PTEN loss abrogates BRAFV600E-induced senescence in human melanocytes and promotes tumor development [61]. This evidence concerns the gene BRAF and neoplasm.